Signature Equity Partners’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$76.5K Sell
1,406
-1,708
-55% -$83.2K 0.04% 348
2026
Q1
$134K Buy
3,114
+1,108
+55% +$47.6K 0.07% 245
2025
Q4
$87.9K Buy
+2,006
New +$83K 0.05% 296

Other funds holding EXEL

Signature Equity Partners's EXEL Position: Q2 2026 in Review

Signature Equity Partners reduced its Exelixis (EXEL) stake by 55% in Q2 2026, selling an estimated $83.2K and leaving 1,406 shares worth $76.5K. The position accounts for 0.04% of the portfolio, ranked #348.

Signature Equity Partners first reported a position in EXEL in Q4 2025 and has held it in 3 quarters since. The position peaked at $134K in Q1 2026. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Signature Equity Partners held 1,406 shares of Exelixis worth $76.5K as of Q2 2026.
  • Signature Equity Partners sold 1,708 Exelixis shares in Q2 2026, an estimated $83.2K.
  • Exelixis made up 0.04% of Signature Equity Partners's portfolio in Q2 2026, its #348 holding.
  • Signature Equity Partners first reported a position in Exelixis in Q4 2025 and has held it in 3 quarters since.
  • Signature Equity Partners's Exelixis position peaked at $134K in Q1 2026.
  • 760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.